Treatment for Osgood Schlatter Patients With a Physiotherapy Program (TrOPhy)

September 12, 2022 updated by: University Hospital, Basel, Switzerland

Treatment for Osgood Schlatter Patients With a Physiotherapy Program "TrOPhy-Study"

This study is to compare the effect of a physiotherapy program to usual care treatment in patients with Osgood Schlatter disease (OSD). Patients will be randomly assigned into two groups. Group 1 will receive the physiotherapy program with myofascial massage, while group 2 (usual care group USC) will receive usual care treatment.

Study Overview

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Basel, Switzerland, 4056
        • Department of Sport, Exercise and Health, Medical Faculty University of Basel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 17 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Uni- or bilateral OSD
  • ability to follow instructions
  • sufficient knowledge of German
  • availability: can participate in two exercise sessions per week for a period of 8 weeks

Exclusion Criteria:

  • any history of knee surgery
  • medication intake affecting the knee
  • unstable fractures
  • neurological disorders
  • systematic diseases
  • already in physiotherapeutic treatment because of the knee
  • not possible to do any physiotherapy sessions at the Universitäts-Kinderspital Basel (UKBB)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group 1 INT (= intervention)

physiotherapy program with

  • Myofascial Release Massage (quadriceps)
  • Foam Rolling lower extremity
  • Knee Isometrics in knee extension (sitting position)
  • Dynamic and static stretching (quadriceps) in half knee position
  • Core Stability (planks)
  • Strengthening (calf raises, good morning,squats, squat jump)
  • Balance (single leg stance)

physiotherapy program with Myofascial Release Massage, stretching, strengthening.

2 sessions per week (duration 30 minutes per session) for 8 weeks, supervised by a physiotherapist; complemented by a home training program.

Placebo Comparator: Group 2 USC (= usual care)

usual care treatment with

  • Core Stability (prone plank)
  • Strengthening: (Hip extension, abduction; Calf raises)
  • Stretching (M. rectus femoris (static) in standing position; Hamstring in sitting position)
  • Balance (single leg stand)
stretching,strengthening; 2 sessions per week (duration 30 minutes per session) for 8 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in Knee and Osteoarthritis Outcome Score for Children (KOOS-Child-Questionnaire Score)
Time Frame: at baseline and 8 weeks after baseline
KOOS-Child is a patient-reported outcome measure employing five-item Likert scales. KOOS-Child covers 5 dimensions (subscales): Pain, Symptoms (titled "Knee problems" in the KOOS-Child), Difficulty during daily activities (ADL), Function in sport and play (Sports/Play) and knee-related Quality of Life (QOL). 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems
at baseline and 8 weeks after baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Knee pain assessed by Visual Analogue Scale (VAS)
Time Frame: at baseline and 8 weeks after baseline
The visual analogue scale (VAS) is a scale used to determine the pain intensity experienced by individuals. It consists of a line, 10 cm in length, with the left side signifying no pain and the right side signifying the worst pain ever.
at baseline and 8 weeks after baseline
Change in Range of motion (ROM) of knee
Time Frame: at baseline and 8 weeks after baseline
Range of motion is typically measured using a goniometer. Normal ROM at the knee is considered to be 0 degrees of extension (completely straight knee joint) to 135 degrees of flexion (fully bent knee joint).
at baseline and 8 weeks after baseline
Change in Y Balance Test (Lower Quarter)
Time Frame: at baseline and 8 weeks after baseline
The Y-Balance Test is a dynamic test performed in a single-leg stance that requires strength, flexibility, core control and proprioception. The goal of this test is to maintain single-leg balance on one leg while reaching as far as possible with the contralateral leg in three different directions. The three movement directions are anterior, posteromedial and posterolateral, performed on each leg. Each test is repeated three times, and the maximum reach in each direction is recorded.
at baseline and 8 weeks after baseline
Time of return to sport activity (in days)
Time Frame: within 8 weeks after baseline
Time of return to sport activity (in days) since start of treatment
within 8 weeks after baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Oliver Faude, PD Dr. med., Department of Sport, Exercise and Health, Medical Faculty University of Basel

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 11, 2020

Primary Completion (Actual)

July 7, 2022

Study Completion (Actual)

July 7, 2022

Study Registration Dates

First Submitted

January 19, 2021

First Submitted That Met QC Criteria

January 19, 2021

First Posted (Actual)

January 20, 2021

Study Record Updates

Last Update Posted (Actual)

September 13, 2022

Last Update Submitted That Met QC Criteria

September 12, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2020-02132; ks20Neuhaus

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osgood-Schlatter Disease

Clinical Trials on physiotherapy program

3
Subscribe